At-home diagnostic system sees growth in older users

Tyto Care conducted more than 650,000 telehealth exams last year as COVID-19 drives increased uptake, including in senior care environments.
The COVID-19 pandemic has driven rapid growth in the global telehealth market. This growth is unlikely to slow down anytime soon, with consulting giant…Read More

Fall detection tech a focus for investors

EchoCare raising funds to target acute fall detection and other emergencies with privacy-sensitive, radar-based system.
In the US-alone, for nonfatal falls, Medicare paid approximately $28.9 billion, Medicaid $8.7 billion and private and other payers $12.0 billion. Back in 2015, overall medical…Read More

Connected care start-up targets aging-in-place

PCL Health monitors key vitals at home, providing caregivers with peace of mind and supporting aging-in-place.
British start-up PCL Health (formerly Poonyah Care) is on a mission to change the way that the health of older people is monitored and managed at-home. The company has developed a range…Read More

AgeTech fund: focus on over-50s not millennials

Founding partner of 1843 Capital targets AgeTech investment opportunities with $13 million fund.
Connecticut-based early stage investment firm 1843 Capital values diversity highly, and seeks investment opportunities that reflect diversity, both in terms of the companies themselves and the markets…Read More

New investor offers funding to healthy aging innovators

A fifth investor has joined UK Research and Innovation (UKRI), providing matched funding for top small innovators to develop ideas for healthy aging.
The new investor in the healthy aging innovation is London-based Nesta; describing themselves as an “impact investor”, Nesta works on thr…Read More

Huma’s $130m raise will scale its digital health platform

With the goal of bringing proactive, predictive care to all, Huma has $130 million financing from leading health and technology companies.
The investment arms of Bayer, Hitachi, Samsung, Sony Innovation Fund by IGV, Unilever and the PE fund HAT are financing Huma Therapeutics Ltd to t…Read More